•EnosiLifeSciences-Logo-Main-BlueGrey.png
Therapeutic Antibody Pioneers Professor Sir Marc Feldmann and Dr. H. Michael Shepard Formally Launch Enosi Life Sciences
September 02, 2020 09:00 ET | Enosi Life Sciences
SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- World-renowned scientists Professor Sir Marc Feldmann and Dr. H. Michael Shepard are pleased to announce the formal launch of Enosi Life Sciences...
Reports and Data.jpeg-01
Immunoassay Analyzers Market To Reach USD 26.40 Billion By 2027 | Reports and Data
August 27, 2020 17:00 ET | Reports and Data
New York, Aug. 27, 2020 (GLOBE NEWSWIRE) -- The Global Immunoassay Analyzers market is forecast to reach USD 26.40 Billion by 2027, according to a new report by Reports and Data. Immunoassay...
Reports and Data.jpeg-01
Autoimmune Disease Diagnosis Market To Reach USD 7.37 Billion By 2027 | Reports and Data
August 20, 2020 17:00 ET | Reports and Data
New York, Aug. 20, 2020 (GLOBE NEWSWIRE) -- The Global Autoimmune Disease Diagnosis Market is forecast to reach USD 7.37 Billion by 2027, according to a new report by Reports and Data. An increase...
Exagen_Full_CMYK_Print.jpg
Exagen Inc. Announces a Collaboration with Hospital for Special Surgery (HSS) for Antiphospholipid Syndrome
August 03, 2020 16:05 ET | Exagen Inc.
SAN DIEGO, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen_Full_CMYK_Print.jpg
Exagen to Present at the Canaccord Genuity 40th Annual Growth Conference
July 30, 2020 16:25 ET | Exagen Inc.
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen_Full_CMYK_Print.jpg
Exagen Inc. Reports Second Quarter 2020 Results
July 28, 2020 07:00 ET | Exagen Inc.
Testing Experiencing Monthly Sequential ImprovementRecord Gross Margins of 63% SAN DIEGO, July 28, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming...
Exagen_Full_CMYK_Print.jpg
Exagen Inc. AVISE Testing Now Covered and In-Network with TRICARE East
July 27, 2020 16:05 ET | Exagen Inc.
SAN DIEGO, July 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Beyond Celiac Awards
Beyond Celiac Awards Nearly $450,000 in Research Grants for Groundbreaking Studies on Celiac Disease
August 16, 2019 08:51 ET | Beyond Celiac
Philadelphia, PA, Aug. 16, 2019 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading research-driven celiac disease organization working to drive diagnosis, advance research and accelerate the discovery...
Last Chance to Regis
Last Chance to Register: Beyond Celiac Global Webinar
October 04, 2018 14:53 ET | Beyond Celiac
Philadelphia, PA, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Thousands have registered for the upcoming live webcast of the Second Annual Beyond Celiac Global Research Symposium. Others who are interested...
Beyond Celiac Webcas
Beyond Celiac Webcast Welcomes a Global Audience
September 06, 2018 14:54 ET | Beyond Celiac
Philadelphia, PA, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Celiac disease and other autoimmune disease sufferers around the world can learn the latest developments in research and treatment by tuning in...